Found: 188
Select item for more details and to access through your institution.
ABSTRACTS of ICPE 2022, the 38th International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE), Copenhagen, Denmark, 26–28 August, 2022: ORAL PRESENTATIONS.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, p. 3, doi. 10.1002/pds.5518
- Publication type:
- Article
Development and validation of case‐finding algorithms to identify acute pancreatitis in the Veterans Health Administration.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 12, p. 1294, doi. 10.1002/pds.5549
- By:
- Publication type:
- Article
Use of α1‐adrenoceptor antagonists tamsulosin and alfuzosin and the risk of Alzheimer's disease.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 10, p. 1110, doi. 10.1002/pds.5503
- By:
- Publication type:
- Article
Glucosamine and lower mortality and cancer incidence: Selection bias in the observational studies.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 12, p. 1272, doi. 10.1002/pds.5535
- By:
- Publication type:
- Article
Development of a multivariate prediction model to identify individual case safety reports which require clinical review.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 12, p. 1300, doi. 10.1002/pds.5553
- By:
- Publication type:
- Article
Record linkage of claims and cancer registries data—Evaluation of a deterministic linkage approach based on indirect personal identifiers.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 12, p. 1287, doi. 10.1002/pds.5545
- By:
- Publication type:
- Article
Incidence and outcomes of adverse drug reactions to first‐line anti‐tuberculosis drugs and their effects on the quality of life: A multicenter prospective cohort study.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 11, p. 1153, doi. 10.1002/pds.5513
- By:
- Publication type:
- Article
Partition testing for real‐world evidence studies.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 12, p. 1280, doi. 10.1002/pds.5540
- By:
- Publication type:
- Article
Untitled.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 12, p. 1317, doi. 10.1002/pds.5543
- By:
- Publication type:
- Article
A systematic review of whether COVID‐19 randomized controlled trials reported on demographic and clinical characteristics.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 12, p. 1219, doi. 10.1002/pds.5533
- By:
- Publication type:
- Article
Joint longitudinal trajectories of pain intensity and opioid prescription in veterans with back pain.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 12, p. 1262, doi. 10.1002/pds.5531
- By:
- Publication type:
- Article
Accuracy and validity of reported opioid prescription days' supply.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 12, p. 1253, doi. 10.1002/pds.5528
- By:
- Publication type:
- Article
Performance characteristics of code‐based algorithms to identify urinary tract infections in large United States administrative claims databases.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 9, p. 953, doi. 10.1002/pds.5492
- By:
- Publication type:
- Article
Artificial intelligence in pharmacovigilance: A regulatory perspective on explainability.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 12, p. 1308, doi. 10.1002/pds.5524
- By:
- Publication type:
- Article
Time‐related biases in perinatal pharmacoepidemiology: A systematic review of observational studies.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 12, p. 1228, doi. 10.1002/pds.5504
- By:
- Publication type:
- Article
Indirect covariate balance and residual confounding: An applied comparison of propensity score matching and cardinality matching.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 12, p. 1242, doi. 10.1002/pds.5510
- By:
- Publication type:
- Article
Artificial intelligence in pharmacovigilance: Do we need explainability?
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 12, p. 1311, doi. 10.1002/pds.5501
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 12, p. 1319, doi. 10.1002/pds.5290
- Publication type:
- Article
Antidepressant exposures associated with exploratory behavior among young children reported to United States poison control centers, 2000–2020.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 11, p. 1206, doi. 10.1002/pds.5534
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 12, p. 1, doi. 10.1002/pds.5498
- Publication type:
- Article
Adverse events in the digital age and where to find them.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 11, p. 1131, doi. 10.1002/pds.5532
- By:
- Publication type:
- Article
Pre‐ and post‐stroke oral antithrombotics and mortality in patients with ischaemic stroke.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 11, p. 1182, doi. 10.1002/pds.5530
- By:
- Publication type:
- Article
Visualizations throughout pharmacoepidemiology study planning, implementation, and reporting.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 11, p. 1140, doi. 10.1002/pds.5529
- By:
- Publication type:
- Article
Thromboembolic events after Ad.26.COV2.S COVID‐19 vaccine: Reports to the Vaccine Adverse Event Reporting System.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 11, p. 1174, doi. 10.1002/pds.5523
- By:
- Publication type:
- Article
A cohort study to assess risk of cutaneous small vessel vasculitis among users of different oral anticoagulants.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 11, p. 1164, doi. 10.1002/pds.5514
- By:
- Publication type:
- Article
Pioglitazone use in Australia and the United Kingdom following drug safety advisories on bladder cancer risk: An interrupted time series study.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 10, p. 1039, doi. 10.1002/pds.5508
- By:
- Publication type:
- Article
Parity in female authorship in Australian pharmacoepidemiology research leveraging medicine dispensing data: How well are we doing?
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 9, p. 1010, doi. 10.1002/pds.5450
- By:
- Publication type:
- Article
Ileus in patients treated with immune checkpoint inhibitors: A retrospective, pharmacovigilance study using Food and Drug Administration Adverse Event Reporting System database.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 11, p. 1199, doi. 10.1002/pds.5493
- By:
- Publication type:
- Article
Antibacterial‐associated acute kidney injury among older adults: A post‐marketing surveillance study using the FDA adverse events reporting system.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 11, p. 1190, doi. 10.1002/pds.5486
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 11, p. 1217, doi. 10.1002/pds.5288
- Publication type:
- Article
Issue Information.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 11, p. 1, doi. 10.1002/pds.5498
- Publication type:
- Article
Metformin, pioglitazone and gout risk.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 10, p. 1127, doi. 10.1002/pds.5516
- By:
- Publication type:
- Article
Kidney function and prescribed dose in middle‐aged and older patients starting selective serotonin reuptake inhibitors.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 10, p. 1091, doi. 10.1002/pds.5515
- By:
- Publication type:
- Article
Comparison of drug prescribing before and during the COVID‐19 pandemic: A cross‐national European study.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 10, p. 1046, doi. 10.1002/pds.5509
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 10, p. 1, doi. 10.1002/pds.5498
- Publication type:
- Article
Potentially inappropriate medication use by level of polypharmacy among US Veterans 49–64 and 65–70 years old.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 10, p. 1056, doi. 10.1002/pds.5506
- By:
- Publication type:
- Article
ISPE20 Author Index.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, p. 679, doi. 10.1002/pds.5521
- Publication type:
- Article
Risk of volume depletion events with concomitant use of sodium glucose co‐transporter 2 inhibitors and loop diuretics: A self‐controlled case series study.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 10, p. 1102, doi. 10.1002/pds.5496
- By:
- Publication type:
- Article
Association between opioid therapy trajectories and potential opioid‐related adverse health events.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 10, p. 1075, doi. 10.1002/pds.5495
- By:
- Publication type:
- Article
Core concepts in pharmacoepidemiology: Measures of drug utilization based on individual‐level drug dispensing data.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 10, p. 1015, doi. 10.1002/pds.5490
- By:
- Publication type:
- Article
Very high PD‐L1 expression as a prognostic indicator of overall survival among patients with advanced non‐small cell lung cancer receiving anti‐PD‐(L)1 monotherapies in routine practice.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 10, p. 1121, doi. 10.1002/pds.5487
- By:
- Publication type:
- Article
Use of prescription medications with cardiovascular adverse effects among older adults in the United States.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 10, p. 1027, doi. 10.1002/pds.5477
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 10, p. 1129, doi. 10.1002/pds.5286
- Publication type:
- Article
Validity of claims data for identifying cancer incidence in the Japan public health center‐based prospective study for the next generation.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 9, p. 972, doi. 10.1002/pds.5494
- By:
- Publication type:
- Article
ISPE20 Author Index.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, p. 679, doi. 10.1002/pds.5521
- Publication type:
- Article
ABSTRACTS of the virtual 2nd Annual African Regional Interest Group Meeting (AfRIG), 11–13 July, 2022.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, p. 654, doi. 10.1002/pds.5520
- Publication type:
- Article
SUPPLEMENTARY ABSTRACTS of ICPE 2021, the 37th International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE), 23–25 August, 2021 (virtual).
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, p. 629, doi. 10.1002/pds.5519
- Publication type:
- Article
Issue Information.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, p. 1, doi. 10.1002/pds.5498
- Publication type:
- Article
ABSTRACTS of the virtual 2nd Annual African Regional Interest Group Meeting (AfRIG), 11–13 July, 2022.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, p. 654, doi. 10.1002/pds.5520
- Publication type:
- Article
SUPPLEMENTARY ABSTRACTS of ICPE 2021, the 37th International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE), 23–25 August, 2021 (virtual).
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, p. 629, doi. 10.1002/pds.5519
- Publication type:
- Article